| Title : Application of a physiologically based pharmacokinetic model for the prediction of mirabegron plasma concentrations in a population with severe renal impairment - Konishi_2019_Biopharm.Drug.Dispos_40_176 |
| Author(s) : Konishi K , Minematsu T , Nagasaka Y , Tabata K |
| Ref : Biopharmaceutics & Drug Disposition , 40 :176 , 2019 |
| Abstract : |
| PubMedSearch : Konishi_2019_Biopharm.Drug.Dispos_40_176 |
| PubMedID: 30985942 |
| Title : Physiologically-based pharmacokinetic modeling for mirabegron: a multi-elimination pathway mediated by cytochrome P450 3A4, uridine 5'-diphosphate-glucuronosyltransferase 2B7, and butyrylcholinesterase - Konishi_2018_Xenobiotica__1 |
| Author(s) : Konishi K , Minematsu T , Nagasaka Y , Tabata K |
| Ref : Xenobiotica , :1 , 2018 |
| Abstract : |
| PubMedSearch : Konishi_2018_Xenobiotica__1 |
| PubMedID: 30301385 |
| Title : Genetic Analysis and Characterization of Poly(aspartic acid) Hydrolase-1 from Sphingomonas sp. KT-1 - Hiraishi_2003_Biomacromolecules_4_80 |
| Author(s) : Hiraishi T , Kajiyama M , Tabata K , Yamato I , Doi Y |
| Ref : Biomacromolecules , 4 :80 , 2003 |
| Abstract : |
| PubMedSearch : Hiraishi_2003_Biomacromolecules_4_80 |
| PubMedID: 12523851 |
| Gene_locus related to this paper: 9sphn-q7wsc1 |
| Title : Purification and characterization of poly(aspartic acid) hydrolase from Sphingomonas sp. KT-1 - Tabata_2001_Biomacromolecules_2_1155 |
| Author(s) : Tabata K , Kajiyama M , Hiraishi T , Abe H , Yamato I , Doi Y |
| Ref : Biomacromolecules , 2 :1155 , 2001 |
| Abstract : |
| PubMedSearch : Tabata_2001_Biomacromolecules_2_1155 |
| PubMedID: 11777387 |